We therefore dismissed them as drivers of cell proliferation in this model of CET resistance and focused on other hallmarks of cancer that drive disease progression, such as cell migration, as EPHA2 is known to regulate cell migration and has been associated with elevated metastatic potential and poor survival in CRC and other malignancies (Xiao et al. 2020). The gene discussed is EPHA2; the disease is cancer.